Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-048792
Filing Date
2025-11-04
Accepted
2025-11-04 16:05:03
Documents
52
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20250930.htm   iXBRL 10-Q 765414
2 EX-31.1 lfvn_93025xex311.htm EX-31.1 9484
3 EX-31.2 lfvn_93025xex312.htm EX-31.2 9464
4 EX-32.1 lfvn_93025xex321.htm EX-32.1 4866
5 EX-32.2 lfvn_93025xex322.htm EX-32.2 4846
  Complete submission text file 0001628280-25-048792.txt   4555385

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20250930.xsd EX-101.SCH 28394
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20250930_cal.xml EX-101.CAL 58650
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20250930_def.xml EX-101.DEF 106506
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20250930_lab.xml EX-101.LAB 482844
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20250930_pre.xml EX-101.PRE 301163
55 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20250930_htm.xml XML 454973
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 251448894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)